Oral ghrelin receptor agonist MK-0677 increases serum insulin-like growth factor 1 in hemodialysis patients: A randomized blinded study
Nephrology Dialysis Transplantation Mar 10, 2018
Campbell GA, et al. - The effect of MK-0677 (an oral ghrelin receptor agonist) vs placebo on insulin-like growth factor 1 (IGF-1) levels in hemodialysis patients was determined. Findings demonstrated MK-0677 increased serum IGF-1 levels with minimal adverse effects in hemodialysis subjects.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty -
Paid Market Research Surveys -
Case discussions, News & Journals' summaries
